For instance, an analysis of sporadic adenocarcinomatous CRC tissues from both the colon and rectum revealed a higher prevalence of CDKN2A methylation in stage II patients (p-value = 0.012) and those without lymph node metastasis (p-value = 0.011). Here, CDKN2A is linked to colorectal carcinoma.